Cargando…
Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
Follistatin is an inhibitor of TGF-β superfamily ligands that repress skeletal muscle growth and promote muscle wasting. Accordingly, follistatin has emerged as a potential therapeutic to ameliorate the deleterious effects of muscle atrophy. However, it remains unclear whether the anabolic effects o...
Autores principales: | Sepulveda, Patricio V., Lamon, Séverine, Hagg, Adam, Thomson, Rachel E., Winbanks, Catherine E., Qian, Hongwei, Bruce, Clinton R., Russell, Aaron P., Gregorevic, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675991/ https://www.ncbi.nlm.nih.gov/pubmed/26657343 http://dx.doi.org/10.1038/srep17535 |
Ejemplares similares
-
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
por: Winbanks, Catherine E., et al.
Publicado: (2012) -
miR-206 Represses Hypertrophy of Myogenic Cells but Not Muscle Fibers via Inhibition of HDAC4
por: Winbanks, Catherine E., et al.
Publicado: (2013) -
Transduction of Skeletal Muscles with Common Reporter Genes Can Promote Muscle Fiber Degeneration and Inflammation
por: Winbanks, Catherine E., et al.
Publicado: (2012) -
Using AAV vectors expressing the β(2)-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size
por: Hagg, Adam, et al.
Publicado: (2016) -
Mechanisms involved in follistatin‐induced hypertrophy and increased insulin action in skeletal muscle
por: Han, Xiuqing, et al.
Publicado: (2019)